Thursday, September 30, 2021 Daily Archives

Iovance opens PA cell therapy plant; produces first batch of lifileucel

The $85 million Iovance Cell Therapy Center (ICTC) has opened its doors at the Philadelphia Navy Yard with capacity to supply thousands of patients per year. Iovance celebrated the opening of its 136,000 square-foot commercial-scale production facility, commissioned in 2018 at a cost of around $85 million, this week. “Since Iovance was founded, we have been dedicated to advancing novel cell therapies for patients with solid tumor cancers,” Iovance CEO Frederick Vogt said. “A little over two years after breaking…

ViroCell partnership to double UK lentivirus vector capacity

ViroCell has partnered with Great Ormond Street Hospital to address the global viral vector manufacturing bottleneck for clinical trials. Contract development manufacturing organization (CDMO) ViroCell Biologics says its partnership with Great Ormond Street Hospital (GOSH) will more than double the UK’s lentivirus vector manufacturing capacity for clinical trials in 2022. Additionally, ViroCell claims the collaboration will secure its position as the first CDMO in the UK to deliver adeno-associated viruses (AAV) vectors to the cell and gene therapy (CGT) markets.…